Last updated on July 2018

Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study

Brief description of study

This is a multi-center prospective, single-arm, non-randomized, open label study to assess feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring Right Ventricular Outflow Tract correction or reconstruction due to congenital heart malformations.

Clinical Study Identifier: NCT03022708

Contact Investigators or Research Sites near you

Start Over

Kirk Kanter, MD

Children's Healthcare of Atlanta
Atlanta, GA United States
  Connect »

Christopher Baird, MD

Boston Children's Hospital
Boston, MA United States
  Connect »

Emile Bacha

New York Presbyterian Hospital - Columbia University
New York, NY United States
  Connect »

J William Gaynor, MD

The Children's Hospital of Philadelphia
Philadelphia, PA United States
  Connect »

Cynthia Herrington, MD

Children's Hospital of Los Angeles
Los Angeles, CA United States
  Connect »

Victor Morell, MD

Children's Hospital of Pittsburgh of UPMC
Pittsburgh, PA United States
  Connect »

James Tweddell, MD

Cincinnati Children's Hospital Medical Center
Cincinnati, OH United States
  Connect »

Max Mitchell, MD

Children's Hospital Colorado
Aurora, CO United States
  Connect »